Role of p300, a transcriptional coactivator, in signalling of TGF-beta
Related Experiment Video
Updated: Oct 27, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
A Nishihara1, J I Hanai, N Okamoto
1Department of Biochemistry, The Cancer Institute, Japanese Foundation for Cancer Research (JFCR), and Research for the Future Program, Japan.
Background:
Smad proteins are novel transcriptional regulators mediating the signalling of the transforming growth factor-beta (TGF-beta) superfamily. Coactivators such as p300/CBP promote transactivation by various transcription factors through a direct interaction with them. Adenoviral oncoprotein E1A, which binds p300, was shown to inhibit the signalling of TGF-beta. These findings raise the possibility that p300 may be involved in TGF-beta signalling.
Results:
We investigated whether p300 is involved in transactivation by Smads. p300 enhanced the Smad-induced transactivation of p3TP-Lux, a TGF-beta responsive reporter. E1A inhibited this enhancement, and the inhibition required its ability to bind p300/CBP. p300 and Smad3, as well as Smad2, interacted in vivo in a ligand-dependent manner. The binding region in Smad3 was its C-terminal half that was previously shown to possess an intrinsic transactivation activity. The binding region in p300 was mapped to its C-terminal 678 amino acids. The minimal Smad2/3-interacting region, as well as the rest of the p300, inhibited the transactivation of p3TP-Lux in a dominant-negative fashion.
Conclusion:
p300 interacted with Smad2 and Smad3 in a ligand-dependent manner, and enhanced the transactivation by Smads. Our results present the molecular basis of the transactivation by Smad proteins.
Insights
p300 protein enhances transforming growth factor-beta (TGF-beta) signaling by interacting with Smad proteins. This interaction is crucial for Smad-mediated gene transcription and is inhibited by adenoviral E1A protein.
Area of Science:
- Molecular Biology
- Cell Signaling
- Transcriptional Regulation
Background:
- Smad proteins are key mediators of transforming growth factor-beta (TGF-beta) superfamily signaling.
- p300/CBP act as coactivators for transcription factors through direct interactions.
- Adenoviral oncoprotein E1A inhibits TGF-beta signaling by binding to p300, suggesting p300's role in this pathway.
Purpose of the Study:
- To investigate the involvement of p300 in Smad-mediated transcriptional activation.
- To elucidate the interaction between p300 and Smad proteins in TGF-beta signaling.
Main Methods:
- Assessed p300's effect on Smad-induced transactivation using the p3TP-Lux reporter assay.
- Investigated the interaction between p300 and Smad proteins in vivo.
- Mapped the binding regions of Smad3 and p300 involved in their interaction.
- Utilized dominant-negative constructs to assess the functional impact of p300-Smad interaction.
Main Results:
- p300 significantly enhanced Smad-induced transactivation of the TGF-beta responsive reporter.
- Adenoviral E1A inhibited p300's enhancement of Smad activity, dependent on E1A's p300-binding capability.
- p300 directly interacted with Smad2 and Smad3 in a ligand-dependent manner.
- Specific binding regions were identified in Smad3 (C-terminal half) and p300 (C-terminal 678 amino acids).
- Dominant-negative inhibition of p300-Smad interaction impaired transactivation.
Conclusions:
- p300 interacts with Smad2 and Smad3 in a ligand-dependent manner.
- p300 enhances Smad-mediated transactivation, providing molecular insights into Smad protein function.
Related Concept Videos
TGF - β Signaling Pathway
Master Transcription Regulators
Co-activators and Co-repressors
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity
Two...
